Elementis plc (ELM.L) Bundle
From its roots in 1844 as Harrisons & Crosfield to a focused specialty-chemicals group, Elementis plc has reshaped itself through targeted deals-most notably the 1998 acquisition of American Rheox for $465 million and the 2018 purchase of Mondo Minerals for $600 million-before refocusing in 2022 with the sale of its Chromium business; today the FTSE 250-listed company (ELM) boasts a market capitalisation of about £945.62 million (Dec 2025), reported $738 million revenue in 2024 (up 3% constant currency), and generated $521 million from Performance Specialties (with Coatings at $386 million, +5%), while Personal Care made up c.30% of sales and 42% of adjusted operating profit; strategic moves in 2025- including a $50 million buyback and the May 2025 Talc sale for $121 million (net cash proceeds ~ $55 million), along with leadership change to Luc van Ravenstein in April 2025-underscore a sharpened capital allocation approach as Elementis drives innovation (new products = 15% of sales in 2024), targets $30 million annual cost savings by end-2025, and enters 2026 aiming for an adjusted operating margin >19% and average operating cash conversion above 90%, supported by a strengthened balance sheet (net debt $157 million, net debt/EBITDA 1.0x at end-2024) and commitments to safety, diversity (42% senior female leaders) and naturally derived solutions (69% of revenues).
Elementis plc (ELM.L): Intro
Elementis plc (ELM.L) is a UK-listed specialty chemicals company with origins dating back to 1844 when Harrisons & Crosfield began trading tea and coffee in London. Over nearly two centuries the business transformed from a trading house into a focused chemicals group listed on the London Stock Exchange, concentrating on high-value additives and performance minerals for coatings, construction, personal care and industrial applications. Elementis plc: History, Ownership, Mission, How It Works & Makes Money- Founded lineage: 1844 (Harrisons & Crosfield)
- Rebranded to Elementis plc: 1997 - strategic shift to specialty chemicals
- Listed: London Stock Exchange (ticker: ELM.L)
History & key transactions
- 1844 - Harrisons & Crosfield established in London (tea & coffee trading origin).
- 1997 - Rebranding to Elementis plc to focus on specialty chemicals.
- 1998 - Acquisition of American Rheox for $465 million; expanded rheology and chromium chemicals capabilities and made Elementis a leading global producer of chromium chemicals and rheological additives for coatings.
- 2002 - Acquisition of OxyChem's chromium chemicals business in the US, increasing market share in chromium-based products.
- 2018 - Acquisition of Mondo Minerals for $600 million, adding premium talc-based additives and expanding the company's footprint in performance minerals.
- 2022 - Sale of the Chromium business to the Yildirim Group, streamlining operations to focus on core specialty additives, talc and functional fluids.
| Year | Event | Transaction value / note |
|---|---|---|
| 1844 | Harrisons & Crosfield founded | - |
| 1997 | Rebranded to Elementis plc | Strategic refocus |
| 1998 | Acquired American Rheox | $465 million |
| 2002 | Acquired OxyChem chromium business (US) | Undisclosed |
| 2018 | Acquired Mondo Minerals | $600 million |
| 2022 | Sold Chromium business to Yildirim Group | Streamlining strategic focus |
Ownership & corporate structure
- Listed public company on the London Stock Exchange (ELM.L) - dispersed institutional and retail ownership typical of FTSE-listed specialty chemicals companies.
- Board and executive management headquartered in London with global manufacturing and R&D sites (Europe, North America, Asia).
- Post-2022 portfolio concentrated on additives (rheology, surfactants), talc-based performance minerals and functional fluids following disposal of the Chromium division.
Mission, strategy and markets
- Mission: to supply specialty chemical additives and minerals that improve performance, sustainability and efficiency across industrial and consumer applications.
- Strategic pillars: high-value specialty products, targeted M&A to add premium product lines (e.g., Mondo Minerals), portfolio simplification (divestment of non-core Chromium business), and innovation in formulation and sustainability.
- End markets: coatings & paints, construction materials, personal care, polymers, oilfield chemicals and industrial applications.
How it works - operations & product lines
- Product groups: rheology modifiers (for coatings and inks), talc-based performance minerals (fillers, functional additives), surfactants and specialty fluids.
- Value chain: R&D & formulation → manufacturing (chemical processing, milling, surface treatment) → technical support and application development → global sales channels (B2B).
- Competitive advantages: specialized application know-how, product quality and consistency, global supply footprint, and legacy customer relationships in coatings and personal care.
How Elementis makes money - revenue drivers & financial characteristics
- Revenue drivers: product volume and average selling prices in coatings additives and talc; new product introductions; geographic mix (EMEA, Americas, APAC); margin improvements from higher-value product mix and operational efficiencies.
- Profit levers: premiumization (higher-margin specialty products like Mondo talcs), cost control, scale in manufacturing, and technical service that supports pricing power.
- Capital allocation: organic R&D, targeted acquisitions (historic examples: American Rheox, Mondo Minerals), and selective divestments (Chromium sale in 2022) to optimize portfolio returns.
| Metric / area | Characteristic / illustrative figure |
|---|---|
| Primary listing | London Stock Exchange (ELM.L) |
| Major historical acquisitions | American Rheox ($465m, 1998); Mondo Minerals ($600m, 2018) |
| Divestment | Chromium business sold to Yildirim Group (2022) |
| Key end-markets | Coatings, construction, personal care, industrial fluids |
| Employees (approx.) | Circa mid-thousands globally (manufacturing, R&D, commercial) |
Elementis plc (ELM.L): History
Elementis plc (ELM.L) is a UK-listed specialty chemicals group focused on additives and functional materials serving personal care, coatings, construction and other industrial markets. Founded through a series of mergers and acquisitions over the 20th century, Elementis has repositioned itself in the 2010s-2020s via portfolio optimisation and targeted disposals to concentrate on higher-margin additives and technology-led products.
- Listed on the London Stock Exchange under the ticker ELM, constituent of the FTSE 250 Index.
- April 2025: Luc van Ravenstein appointed CEO, marking a new strategic phase in leadership.
- May 2025: Sale of the Talc business for $121 million; net cash proceeds ~ $55 million.
- May 2025: Announced a $50 million share buyback programme to return capital to shareholders.
| Metric | Value | Date |
|---|---|---|
| Market Capitalisation | £945.62 million | December 2025 |
| Talc Business Sale Price | $121 million | May 2025 |
| Net Cash Proceeds from Talc Sale | ~$55 million | May 2025 |
| Share Buyback | $50 million | Announced May 2025 |
| CEO | Luc van Ravenstein | Appointed April 2025 |
Ownership Structure
- Publicly traded equity with a diverse shareholder base: institutional investors, retail holders and employee share schemes.
- Institutional investors hold a significant portion of free float, typical for FTSE 250 constituents.
- Active capital returns (buybacks and disposals) used to optimise shareholder value and balance sheet strength.
Mission
- Deliver advanced additives and functional materials that improve product performance for customers across target end-markets.
- Drive sustainable growth through product innovation, operational efficiency and disciplined capital allocation.
How Elementis Works & Makes Money
Elementis generates revenue by developing, manufacturing and selling speciality chemical additives and functional ingredients. The business model combines product development, custom formulation services and global manufacturing & distribution.
- Revenue streams: sales of personal care ingredients, coatings additives, industrial additives and speciality chemicals to B2B customers.
- Value drivers: proprietary chemistry, formulation expertise, long-term customer contracts and geographic reach.
- Profit deployment: proceeds from disposals (e.g., Talc sale) and buybacks are used to strengthen the balance sheet and return capital to shareholders.
For a deeper look at investor composition and recent activity: Exploring Elementis plc Investor Profile: Who's Buying and Why?
Elementis plc (ELM.L): Ownership Structure
Elementis plc is a specialty chemicals group focused on performance additives, refining chromite-based specialties and surface treatments for industries including coatings, personal care, oil & gas, and construction. The company operates a purpose-driven culture built around Safety, Team, Respect, Solutions and Ambition, and has a stated ambition to be a zero-injury business, investing in proactive safety systems and wellbeing programs across its global operations.- Safety: explicit zero-injury objective, comprehensive HSE programs and continuous training.
- People & Inclusion: senior female leaders now represent 42% of the company's senior team.
- Innovation: new products accounted for 15% of total sales in 2024, underscoring a R&D-led growth approach.
- Operational excellence: the 'Fit for the Future' program targets organisational optimisation and improved efficiency.
- Product sales: specialty additives and performance chemicals sold to industrial and consumer-facing manufacturers.
- Innovation-led premiums: new and differentiated formulations yield higher-margin sales (15% of 2024 sales from new products).
- Integrated supply chain: chromite and mineral processing capabilities support margin stability in select product lines.
- Operational programmes: cost and productivity initiatives (e.g., Fit for the Future) improve EBITDA conversion and cash flow generation.
| Metric | 2024 / Program |
|---|---|
| Senior female leaders | 42% |
| Sales from new products | 15% of total sales (2024) |
| Strategic safety target | Zero-injury business |
| Key transformation initiative | Fit for the Future (operational excellence) |
Elementis plc (ELM.L): Mission and Values
Elementis plc (ELM.L) is a specialty chemicals company organized around two principal operating segments - Performance Specialties and Personal Care - that supply formulation additives, talc and active ingredients to industrial and consumer markets worldwide. The group combines a global manufacturing footprint, targeted R&D investment and operational-improvement programs to deliver margin-accretive growth and resilient cash generation. How it works- Two-segment structure: Performance Specialties and Personal Care, each focused on differentiated chemistries and close-to-customer technical support.
- Global manufacturing & supply: production sites across the United States, Europe and Asia to service regional formulators and multinational customers with local inventory and technical service.
- Customer-facing R&D and applications: laboratory, application and technical service teams that tailor rheology and additive solutions to coatings, plastics, personal care and other value chains.
- Operational excellence programs: continuous cost, footprint and supply-chain initiatives (e.g., the 'Fit for the Future' program) to improve margins and responsiveness.
| Segment | Core Products / Applications | Typical End Markets |
|---|---|---|
| Performance Specialties | Rheological modifiers, polymer additives, talc | Coatings, plastics, technical ceramics, paper, construction |
| Personal Care | Rheological modifiers, compounded blends, antiperspirant actives (aluminium chlorohydrate), deodorant ingredients | Skin care, hair care, deodorants/antiperspirants, color cosmetics |
- Sites in North America, Europe and Asia enable multi-region supply and shorter lead times for large personal-care and coatings customers.
- Strategic talc and compounding facilities underpin scale for both industrial customers (talc for ceramics, plastics) and consumer-packaged-goods customers (compounded rheology systems).
- Investment in capacity and regional technical centers (for example, a new R&D and support centre in Porto, Portugal) strengthens local application support and shortens product development cycles.
- Dedicated R&D teams focus on new rheology modifiers, surface-treated minerals and formulated blends to improve performance, sustainability and regulatory compliance.
- Porto R&D & support centre (recently announced) expands lab capacity and customer-facing development for EMEA personal care and specialty applications.
- 'Fit for the Future' targets a leaner organizational structure, improved procurement and strengthened supply-chain capabilities to reduce working capital and raise free cash flow conversion.
- Program outcomes include site rationalisations, improved logistics routing and digitalisation of planning systems to reduce lead times and inventory.
- Product sales: recurring revenue from additives, talc and compounded products sold into coatings, plastics and personal care formulators.
- Value-added services: technical support, bespoke formulations and small-batch compounding that command premium margins.
- Geographic mix: revenue diversification by region (Americas, EMEA, Asia) reduces single-market demand risk and captures local pricing differentials.
- Operational leverage: margin expansion through fixed-cost absorption as volumes recover and through Fit for the Future cost savings.
| Metric | Latest reported (approx.) |
|---|---|
| Annual revenue | ~£365-385 million (recent FY) |
| Adjusted operating profit | ~£40-55 million (recent FY) |
| Net debt | ~£80-110 million |
| Dividend per share | Mid-single-digit to low-double-digit pence per share (policy tied to cash generation) |
| ROCE / margin drivers | Improvement targeted via mix shift to higher-margin personal care and operational cost reduction programs |
- Coatings and construction: demand tied to industrial capex and housing / infrastructure cycles; specialty rheology and additives improve application and film properties.
- Plastics and technical ceramics: talc and fillers used to modify mechanical and thermal properties; demand correlates with automotive, consumer durables and industrial production.
- Personal care: stable, higher-margin revenue from formulators seeking regulatory-compliant actives and texture modifiers; growth driven by premiumization and new product launches.
- Reinvest in targeted capacity and application labs (e.g., Porto centre) to win new contracts and support innovation-led growth.
- Maintain disciplined balance-sheet management to support dividends, occasional bolt-on M&A in adjacent specialty chemistries, and operational improvement funding.
Elementis plc (ELM.L): How It Works
Elementis plc (ELM.L) is a speciality chemicals company that manufactures and sells high-performance additives and functional ingredients primarily into Coatings, Personal Care and industrial applications. Its model centers on selling higher-margin, value-added products (rheology modifiers, film formers, functional pigments, talc specialties) rather than commodity chemicals, enabling stronger pricing power and customer partnerships. How Elementis makes money- Primary revenue from specialised additives sold to formulated product manufacturers (coatings, personal care, construction, plastics).
- Focus on high-margin Coatings and Personal Care markets where technical performance and regulatory/clean-label attributes command premium pricing.
- Sales mix emphasises innovation and natural/naturally-derived ingredients to capture margin and growth.
| Metric | 2024 | Notes |
|---|---|---|
| Total revenue | $738 million | +3% on constant currency vs prior year |
| Performance Specialties revenue | $521 million | Includes Coatings and Talc |
| Coatings sales | $386 million | +5% vs prior year |
| Personal Care contribution | ~30% of revenue | Sales rose 4% in 2024 |
| Personal Care profit contribution | 42% of Group adjusted operating profit | Disproportionate margin contribution |
| New product sales | 15% of total sales | Indicator of R&D-led growth |
| Natural / naturally derived revenues | 69% of revenues | Reflects portfolio positioning |
| Cost savings target | $30 million p.a. | Target to be achieved by end-2025 |
- Volume growth in Coatings and Personal Care: formulators increasing use of rheology modifiers and performance additives.
- Pricing actions: strategic pricing on differentiated products to offset raw material inflation.
- Mix shift to higher-margin speciality products (new product introductions accounted for 15% of sales in 2024).
- Geographic and end-market diversification to smooth cyclical swings.
- Targeted £/$30 million annual cost savings by end-2025 through manufacturing efficiencies, procurement optimisation and overhead reduction.
- Focus on margin expansion via product mix (Personal Care delivering 42% of adjusted operating profit despite ~30% revenue share).
- Supply chain optimisation to reduce unit costs and improve service levels to strategic customers.
- New products represented 15% of sales in 2024, demonstrating R&D-driven revenue growth.
- 69% of revenues come from natural or naturally derived products, supporting sustainability and customer demand for clean-label ingredients.
- Close collaboration with formulators to develop bespoke solutions that command higher margins and longer-term contracts.
- Manufacturing network focused on flexible specialty production to support rapid scale-up of higher-value products.
- Technical sales and application labs embedded with customers to integrate additives into formulations and validate performance claims.
- Channel: direct sales to global formulators, regional distribution partners in selected markets.
| Indicator | Implication |
|---|---|
| Revenue growth (3% cc) | Underlying demand recovery driven by volume and pricing |
| Coatings growth (5%) | Resilient industrial demand and successful market penetration |
| Personal Care profitability share (42%) | Higher-margin segment, strong cash generation |
| New product sales (15%) | Pipeline monetisation and competitive differentiation |
| Natural-derived revenues (69%) | Alignment with sustainability trends and regulatory tailwinds |
Elementis plc (ELM.L): How It Makes Money
Elementis generates revenue by selling specialty chemical additives and pigments to coatings, personal care, construction, and industrial markets across the United States, Europe and Asia. The business model focuses on high-margin, value-added products, technical service, and long-term supply contracts, backed by global manufacturing and R&D.- Core end-markets: Coatings, Personal Care, Construction, Oil & Gas and Industrial applications.
- Revenue drivers: Specialty additives, rheology modifiers, corrosion inhibitors, and pigments with technical support and formulation expertise.
- Geographic mix: Significant operations and sales in the US, Europe and Asia to balance regional demand cycles.
| Metric | 2024 / Reported | Near-term Target (2026) |
|---|---|---|
| Net debt | $157 million | Maintain low leverage (net debt / EBITDA ~1.0x) |
| Net debt / EBITDA | 1.0x | ~1.0x |
| Adjusted operating profit margin | - (2024 performance improving) | >19% |
| Operating cash conversion (3-year average) | - | >90% |
| Shareholder returns | $50m buyback announced; final dividend 2.9 US cents per share (2024) | Continued progressive returns |
- Financial health: Net debt reduced to $157m by end-2024 and net debt/EBITDA ~1.0x improves financial flexibility for M&A, capex and shareholder distributions.
- Profitability focus: Targeting >19% adjusted operating margin through pricing, portfolio mix and cost efficiency.
- Capital allocation: $50m share buyback plus a recommended final dividend of 2.9 cents per share for 2024 signals confidence in cash flow generation.
- Growth & innovation: Continued R&D and new product launches in coatings and personal care to capture higher-margin opportunities and defend market share.
Elementis plc (ELM.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.